TITLE

Nosocomial Enterobacter Meningitis: Risk Factors, Management, and Treatment Outcomes

AUTHOR(S)
Parodi, Stephen; Lechner, Arno; Osih, Regina; Vespa, Paul; Pegues, David
PUB. DATE
July 2003
SOURCE
Clinical Infectious Diseases;7/15/2003, Vol. 37 Issue 2, p159
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Enterobacter species are increasingly a cause of nosocomial meningitis among neurosurgery patients, but risk factors for these infections are not well defined. A review of all adult patients hospitalized at the University of California-Los Angeles (UCLA) Medical Center during an 8-year period identified 15 postneurosurgical cases of Enterobacter meningitis (EM). Cure was achieved in 14 cases (93%), and efficacy was similar for carbapenem- and cephalosporin-based treatment. A matched case-control study comparing 26 controls with 13 case patients hospitalized exclusively at the UCLA Medical Center found that external cerebrospinal fluid (CSF) drainage devices (odds ratio [OR], 21.8; P = .001), isolation of Enterobacter species from a non-CSF culture (OR, 24.6; P = .002), and prolonged administration of antimicrobial drugs before the diagnosis of meningitis that were inactive in vitro against Enterobacter species (OR, 13.3;P = .008) were independent risk factors for EM. Despite favorable treatment outcomes, EM is a serious infection associated with Enterobacter species colonization or infection at other surgical sites, with selective antimicrobial pressure, and with invasive CNS devices.
ACCESSION #
10360961

 

Related Articles

  • Activity of faropenem against cephalosporin-resistant Enterobacteriaceae. Shazad Mushtaq; Russell Hope; Marina Warner; David M. Livermore // Journal of Antimicrobial Chemotherapy (JAC);May2007, Vol. 59 Issue 5, p1025 

    Background There is a need for new oral agents active against extended-spectrum β-lactamase (ESBL) producers, as these increasingly cause community-onset infections. We therefore evaluated faropenem, a penem in Phase III development, against recently collected...

  • Successful Treatment of Gram--Negative Bacillary Meningitis with Moxalactam. Olson, David A.; Hoeprich, Paul D.; Nolan, Sheila M.; Goldstein, Elliot // Annals of Internal Medicine;Sep81, Vol. 95 Issue 3, p302 

    Presents a study on the treatment of gram-negative bacillary meningitis with the cephalosporin moxalactam. Methodology; Case reports on the disease; Discussion.

  • Impact of Previous Use of Antibiotics on Development of Resistance to Extended-Spectrum Cephalosporins in Patients with Enterobacter Bacteremia. Lee, S.-O.; Kim, Y. S.; Kim, B. N.; Kim, M.-N.; Woo, J.-H.; Ryu, J. // European Journal of Clinical Microbiology & Infectious Diseases;Aug2002, Vol. 21 Issue 8, p577 

    This retrospective study was conducted to determine the risk factors for resistance to extended-spectrum cephalosporins (ESCs) and to examine the influence of previous use of an aminoglycoside with an ESC on resistance to ESCs in patients with Enterobacter bacteremia from January 1991 through...

  • Invasive Enterobacter sakazakii Disease in Infants. Bowen, Anna B.; Braden, Christopher R. // Emerging Infectious Diseases;Aug2006, Vol. 12 Issue 8, p1185 

    Enterobacter sakazakii kills 40%-80% of infected infants and has been associated with powdered formula. We analyzed 46 cases of invasive infant E. sakazakii infection to define risk factors and guide prevention and treatment. Twelve infants had bacteremia, 33 had meningitis, and 1 had a urinary...

  • Bloodstream Infections Caused by Enterobacter Species: Predictors of 30-Day Mortality Rate and Impact of Broad-Spectrum Cephalosporin Resistance on Outcome. Cheol-In Kang; Sung-Han Kim; Wan Beom Park; Ki-Deok Lee; Hong-Bin Kim; Myoung-don Oh; Eui-Chong Kim; Kang-Won Choe // Clinical Infectious Diseases;9/15/2004, Vol. 39 Issue 6, p812 

    Background. Enterobacter species have become increasingly important nosocomial pathogens. However, resistance to cephalosporins often complicates the treatment of Enterobacter infection. This study was conducted to evaluate the predictors of mortality and the impact of cephalosporin resistance...

  • Faecal carriage of multidrug-resistant Gram-negative bacilli during a non-outbreak situation in a French university hospital. Vidal-Navarro, Laure; Pfeiffer, Caroline; Bouziges, Nicole; Sotto, Albert; Lavigne, Jean-Philippe // Journal of Antimicrobial Chemotherapy (JAC);Nov2010, Vol. 65 Issue 11, p2455 

    Objectives To determine the prevalence of multidrug-resistant (MDR) Gram-negative bacilli and extended spectrum β-lactamase (ESBL)-producing isolates in stool specimens obtained from patients hospitalized for acute diarrhoea in a French university hospital. Methods Bacteria in stool specimens...

  • Enterobacter Bacteremia: Clinical Features, Risk Factors for Multiresistance and Mortality in a Chinese University Hospital. Ye, Y.; Li, J. B.; Ye, D. Q.; Jiang, Z. J. // Infection;Oct2006, Vol. 34 Issue 5, p252 

    This study was performed to characterize the clinical features and to identify the risk factors for multiresistance and mortality in patients with Enterobacter bacteremia. A number of 126 patients with Enterobacter bacteremia in 1995–2004 at the Medical university-affiliated Hospital of...

  • First identification of an IMI-1 carbapenemase-producing colistin-resistant Enterobacter cloacae in China. Liang Huang; Xiaohui Wang; Yu Feng; Yi Xie; Liping Xie; Zhiyong Zong // Annals of Clinical Microbiology & Antimicrobials;11/25/2015, Vol. 14, p1 

    Background: Carbapenem resistance among the Enterobacteriaceae is a serious healthcare challenge. blaIMI is a carbapenemase gene mediating resistance to carbapenems but has not been commonly found. A blaIMI-carrying Enterobacter cloacae, which was also resistant to colistin, is reported here....

  • Cephalothin and Cephaloridine Therapy for Bacterial Meningitis. Fisher, Larry S.; Chow, Anthony W.; Yoshikawa, Thomas T.; Guze, Lucien B. // Annals of Internal Medicine;May75, Vol. 82 Issue 5, p689 

    Presents a study which examined the efficacy of cephalotin and cephaloridine therapy for bacterial meningitis. Literature review; Diagnosis of bacterial meningitis; Results and discussion.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics